Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O.
Haematologica 87(8): 894-896
2002
ISSN/ISBN: 0390-6078 PMID: 12161373 Document Number: 550612
Document emailed within 1 workday
Related Documents
Weisser, M.; Tischer, J.; Schnittger, S.; Schoch, C.; Ledderose, G.; Kolb, H.Jochem. 2006: A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation Haematologica 91(5): 663-666Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
Brinch, L.; Tjønnfjord, G.; Gedde-Dahl, T.; Heldal, D.; Holme, Pål.André.; Dybedal, I. 2008: Allogeneic stem cell transplantation in acute myelogenous leukemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(15): 1681-2; Author Reply 1682
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Kantarjian, H.M.; Talpaz, M.; Andersson, B.; Khouri, I.; Giralt, S.; Rios, M.B.; Champlin, R.; Hester, J.; Deisseroth, A.B. 1994: High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia Bone Marrow Transplantation 14(1): 57-61
Gómez, M.; Urbano-Ispizua, A.; Cervantes, F.; Fernández-Avilés, F.; Rovira, M.; Carreras, E. 2002: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation Haematologica 87(9): 1003-1005
Basak, G.; Torosian, T.; Snarski, E.; Niesiobedzka, J.; Majewski, M.; Gronkowska, A.; Urbanowska, E.; Jedrzejczak, W. 2010: Hematopoietic stem cell transplantation for T315I-mutated chronic myelogenous leukemia Annals of Transplantation 15(2): 68-70
Kmonícek, M.; Jebavý, L.; Lánská, M.; Zák, P.; Malý, J.; Maisnar, V. 2000: The treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen Vnitrni Lekarstvi 46(7): 377-383
Zikos, P.; Van Lint, M.T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Bregante, S.; Berisso, G.; Mordini, N.; Incagliato, M.; Fugazza, G.; Sessarego, M.; Bacigalupo, A. 1998: Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse Haematologica 83(10): 896-903
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Fagioli, F.; Ricchiardi, A.; Carnevale-Schianca, F. 2002: Non-myeloablative allogeneic hematopoietic stem cell transplants Haematologica 87(8 Suppl): 13-19
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Tomás, J.F.; Peñarrubia, M.J.; García, J.A.; Figuera, A.; Gómez-García de Soria, V.; Steegmann, J.L.; Arranz, R.; Cámara, R.; Gabriel, R.; Vázquez, L. 1995: Allogeneic bone marrow transplantation in chronic myeloid leukemia. the clinical results and risk factors in 70 patients Medicina Clinica 105(16): 605-611
Huang, X.; Wang, F.; Guo, N. 2001: Allogeneic peripheral blood stem cell transplantation for high-risk leukemia Zhonghua Yi Xue Za Zhi 81(22): 1348-1351
Barrios, M.; Jiménez-Velasco, A.; Román-Gómez, Jé.; Madrigal, Mía.Elena.; Castillejo, J.Antonio.; Torres, A.; Heiniger, A. 2003: Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia Haematologica 88(7): 801-810
Rao, S.G.; Kothari, V.; Nadkarni, K.; Ahuja, H.; Advani, S. 1987: Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies Nouvelle Revue Francaise d'Hematologie 29(4): 231-236
Spinelli, O.; Giussani, U.; Borleri, G.; Lazzari, M.; Michelato, A.; Dotti, G.; Barbui, T.; Rambaldi, A. 2000: Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation Haematologica 85(11): 1153-1157
Armitage, J.O. 1992: Myeloablative regimens in peripheral stem cell transplantation Leukemia 6(Suppl 4): 88-89
Sullivan, K.M.; Goldmuntz, E.A.; Keyes-Elstein, L.; McSweeney, P.A.; Pinckney, A.; Welch, B.; Mayes, M.D.; Nash, R.A.; Crofford, L.J.; Eggleston, B.; Castina, S.; Griffith, L.M.; Goldstein, J.S.; Wallace, D.; Craciunescu, O.; Khanna, D.; Folz, R.J.; Goldin, J.; St Clair, E.William.; Seibold, J.R.; Phillips, K.; Mineishi, S.; Simms, R.W.; Ballen, K.; Wener, M.H.; Georges, G.E.; Heimfeld, S.; Hosing, C.; Forman, S.; Kafaja, S.; Silver, R.M.; Griffing, L.; Storek, J.; LeClercq, S.; Brasington, R.; Csuka, M.E.; Bredeson, C.; Keever-Taylor, C.; Domsic, R.T.; Kah 2018: Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma New England Journal of Medicine 378(1): 35-47
Cheong, S.-K.; Eow, G.-I.; Leong, C.-F. 2002: Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work? Malaysian Journal of Pathology 24(1): 1-8